Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRNA vs BP✓SelectedUSD · BPMRNA vs BP performance historyLatest closeAs of+1.29%11/19
Stock and ETF performance explorer

MRNA vs BP

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+971.7%
BP return
+65.8%
Excess return
+905.8%
Maximum drawdown
-95.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioBPExcessAlpha
1D+1.3%-0.1%+1.4%+1.3%
7D-13.8%-4.6%-9.2%-13.9%
30D-17.7%-11.5%-6.2%-17.8%
3M+14.3%-0.1%+14.4%+14.2%
6M+336.0%-4.1%+340.1%+336.3%
YTD+575.9%+30.5%+545.4%+571.2%
1Y+724.4%+26.1%+698.3%+718.9%
3Y+160.8%+42.5%+118.3%+157.0%
5Y-24.4%+111.3%-135.7%-21.9%
All+971.7%+65.8%+905.8%+1,227.0%

Cumulative growth

Daily Returns

Daily percentage return beside BP.

Daily Out/Under-Performance

Portfolio return minus BP return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × BP return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded BP wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling